The MLL leukemia

Acute lymphoblastic leukemia with mixed-lineage leukemia gene (MLL) translocations has a particularly poor prognosis, but it is not clear if host-related factors or tumor-intrinsic biological differences are responsible for these poor survival rates. In December 3 on line Nature Genetics, Scott Armstrong and colleagues from Dana-Farber Cancer Institute, Boston, Massachusetts, show that acute leukemia with MLL translocations has a gene expression profile that identifies them as a unique, new type

By | December 5, 2001

Acute lymphoblastic leukemia with mixed-lineage leukemia gene (MLL) translocations has a particularly poor prognosis, but it is not clear if host-related factors or tumor-intrinsic biological differences are responsible for these poor survival rates. In December 3 on line Nature Genetics, Scott Armstrong and colleagues from Dana-Farber Cancer Institute, Boston, Massachusetts, show that acute leukemia with MLL translocations has a gene expression profile that identifies them as a unique, new type of leukemia.

Armstrong et al. analyzed RNA on microchips and found that lymphoblastic leukemia with MLL translocations has a gene expression profile consistent with an early hematopoietic progenitor expressing select multilineage markers and individual HOX genes. In addition, clustering algorithms reveal that MLL leukemia can clearly be separated from conventional acute lymphoblastic and acute myelogenous leukemias (Nat Genet 2001, DOI: 10.1038/765).

These results suggest that MLL leukemia is a critical unique entity and "mandates the examination of selectively expressed genes for urgently needed molecular targets", concluded the authors.

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS